REQUEST A DEMO
Total
USD $0.00
Search more companies

Uni Pharma Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
Full name: Uni Pharma Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Uni Pharma Co., Ltd.. is a subsidiary of Jianya group. Its main business is diagnostic reagents, medical equipment and pharmaceutical wholesalers. Uni Pharma was established in 1999 and located in Taipei City.

Headquarters
3F., No.17, Ln. 171, Sec. 2, Jiuzong Rd,Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Uni Pharma Co., Ltd. report to view the information.

Website: http://www.uni-pharma.com

Basic Information
Total Employees:
Purchase the Uni Pharma Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Uni Pharma Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Uni Pharma Co., Ltd. report to view the information.
Incorporation Date:
December 23, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.66%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
0.23%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Ho Yao Biopharm Co., Ltd.
15%
NaviFUS Corporation
4.08%
Pharmigene, Inc.
0.81%
Company Performance
Financial values in the chart are available after Uni Pharma Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
2.07%
Total operating revenue
7.97%
Operating profit (EBIT)
49.26%
EBITDA
50.56%
Net Profit (Loss) for the Period
54.28%
Total assets
-14.61%
Total equity
-13.89%
Operating Profit Margin (ROS)
24.5%
Net Profit Margin
25.7%
Return on Equity (ROE)
2.82%
Quick Ratio
2.26%
Cash Ratio
-0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?